These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
402 related articles for article (PubMed ID: 24521454)
1. Targeting the Fc receptor in autoimmune disease. Li X; Kimberly RP Expert Opin Ther Targets; 2014 Mar; 18(3):335-50. PubMed ID: 24521454 [TBL] [Abstract][Full Text] [Related]
2. Understanding Fc Receptor Involvement in Inflammatory Diseases: From Mechanisms to New Therapeutic Tools. Ben Mkaddem S; Benhamou M; Monteiro RC Front Immunol; 2019; 10():811. PubMed ID: 31057544 [TBL] [Abstract][Full Text] [Related]
3. The impact of Fc receptors on the development of autoimmune diseases. Kleinau S Curr Pharm Des; 2003; 9(23):1861-70. PubMed ID: 12871190 [TBL] [Abstract][Full Text] [Related]
4. The prospects for targeting FcR as a novel therapeutic strategy in rheumatoid arthritis. Wu Y; Pan W; Hu X; Zhang A; Wei W Biochem Pharmacol; 2021 Jan; 183():114360. PubMed ID: 33301760 [TBL] [Abstract][Full Text] [Related]
5. Fc receptor targeting in the treatment of allergy, autoimmune diseases and cancer. Nakamura A; Kubo T; Takai T Adv Exp Med Biol; 2008; 640():220-33. PubMed ID: 19065795 [TBL] [Abstract][Full Text] [Related]
6. Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond. Hogarth PM; Pietersz GA Nat Rev Drug Discov; 2012 Mar; 11(4):311-31. PubMed ID: 22460124 [TBL] [Abstract][Full Text] [Related]
7. Fc receptor targeting in the treatment of allergy, autoimmune diseases and cancer. Nakamura A; Akiyama K; Takai T Expert Opin Ther Targets; 2005 Feb; 9(1):169-90. PubMed ID: 15757489 [TBL] [Abstract][Full Text] [Related]
8. Protection in antibody- and T cell-mediated autoimmune diseases by antiinflammatory IgG Fcs requires type II FcRs. Fiebiger BM; Maamary J; Pincetic A; Ravetch JV Proc Natl Acad Sci U S A; 2015 May; 112(18):E2385-94. PubMed ID: 25870292 [TBL] [Abstract][Full Text] [Related]
9. Fc Receptor Variants and Disease: A Crucial Factor to Consider in the Antibody Therapeutics in Clinic. Kim J; Lee JY; Kim HG; Kwak MW; Kang TH Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502398 [TBL] [Abstract][Full Text] [Related]
11. Regulation of antibody production mediated by Fc gamma receptors, IgG binding factors, and IgG Fc-binding autoantibodies. Gergely J; Sármay G; Rajnavölgyi E Crit Rev Biochem Mol Biol; 1992; 27(3):191-225. PubMed ID: 1587143 [TBL] [Abstract][Full Text] [Related]
12. Polymorphisms of immunoglobulin receptors and the effects on clinical outcome in cancer immunotherapy and other immune diseases: a general review. Kaifu T; Nakamura A Int Immunol; 2017 Jul; 29(7):319-325. PubMed ID: 28910969 [TBL] [Abstract][Full Text] [Related]
13. The role of Fc receptors and complement in autoimmunity. Mihai S; Nimmerjahn F Autoimmun Rev; 2013 Apr; 12(6):657-60. PubMed ID: 23201918 [TBL] [Abstract][Full Text] [Related]
14. Fc receptors and their role in immune regulation and autoimmunity. Takai T J Clin Immunol; 2005 Jan; 25(1):1-18. PubMed ID: 15742153 [TBL] [Abstract][Full Text] [Related]
16. Fc receptors gone wrong: A comprehensive review of their roles in autoimmune and inflammatory diseases. Chalayer E; Gramont B; Zekre F; Goguyer-Deschaumes R; Waeckel L; Grange L; Paul S; Chung AW; Killian M Autoimmun Rev; 2022 Mar; 21(3):103016. PubMed ID: 34915182 [TBL] [Abstract][Full Text] [Related]
17. Involvement of Fc receptors in disorders of the central nervous system. Okun E; Mattson MP; Arumugam TV Neuromolecular Med; 2010 Jun; 12(2):164-78. PubMed ID: 19844812 [TBL] [Abstract][Full Text] [Related]
18. Negative signaling in Fc receptor complexes. Daëron M; Lesourne R Adv Immunol; 2006; 89():39-86. PubMed ID: 16682272 [TBL] [Abstract][Full Text] [Related]